By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mast Therapeutics 

12390 El Camino Real, Suite 150

San Diego  California  92130  U.S.A.
Phone: 858-552-0866 Fax: 858-552-0876


Company News
Mast Therapeutics (MSTX) Announces Pricing Of Underwritten Public Offering 2/10/2016 7:28:26 AM
Mast Therapeutics (MSTX) Announces Proposed Public Offering Of Common Stock And Warrants 2/10/2016 6:18:46 AM
Mast Therapeutics (MSTX) To Present At 2016 BIO CEO & Investor Conference On February 8th 2/2/2016 9:14:06 AM
Mast Therapeutics (MSTX)' AIR001 Selected By The Heart Failure Clinical Research Network For Evaluation In A 100-Patient Multicenter Phase 2 Study 2/1/2016 10:15:43 AM
Mast Therapeutics (MSTX) Announces Positive Top-Line Results From Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Conducted At Mayo Clinic 2/1/2016 6:21:17 AM
Mast Therapeutics (MSTX) Provides Business Update 1/7/2016 11:36:04 AM
Mast Therapeutics (MSTX) To Present At The Piper Jaffray 27th Annual Healthcare Conference 11/24/2015 7:37:28 AM
Mast Therapeutics (MSTX) Release: Vepoloxamer Data Selected For Presentation At 57th Annual American Society of Hematology Meeting 11/16/2015 10:24:43 AM
Mast Therapeutics (MSTX) Reports Third Quarter 2015 Financial Results 11/12/2015 4:38:57 PM
Mast Therapeutics (MSTX) Release: Vepoloxamer Nonclinical Study Results In Advanced Heart Failure To Be Presented At 2015 American Heart Association Scientific Sessions 11/9/2015 10:59:14 AM